RNA Profiles of Tear Fluid Extracellular Vesicles in Patients with Dry Eye-Related Symptoms

Int J Mol Sci. 2023 Oct 20;24(20):15390. doi: 10.3390/ijms242015390.

Abstract

Currently, diagnosing and stratifying dry eye disease (DED) require multiple tests, motivating interest in a single definitive test. The purpose of this study was to investigate the potential for using tear fluid extracellular vesicle (EV)-RNA in DED diagnostics. With a role in intercellular communication, nanosized EVs facilitate the protected transport of diverse bioactive molecules in biofluids, including tears. Schirmer strips were used to collect tears from 10 patients presenting with dry eye-related symptoms at the Norwegian Dry Eye Clinic. The samples comprised two groups, five from patients with a tear film break-up time (TBUT) of 2 s and five from patients with a TBUT of 10 s. Tear fluid EV-RNA was isolated using a Qiagen exoRNeasy Midi Kit, and the RNA was characterized using Affymetrix ClariomTM D microarrays. The mean signal values of the two groups were compared using a one-way ANOVA. A total of 26,639 different RNA transcripts were identified, comprising both mRNA and ncRNA subtypes. Approximately 6% of transcripts showed statistically significant differential abundance between the two groups. The mRNA sodium channel modifier 1 (SCNM1) was detected at a level 3.8 times lower, and the immature microRNA-130b was detected at a level 1.5 times higher in the group with TBUT 2 s compared to the group with TBUT 10 s. This study demonstrates the potential for using tear fluid EV-RNA in DED diagnostics.

Keywords: RNA; dry eye disease; extracellular vesicles; tear film break-up time.

MeSH terms

  • Dry Eye Syndromes* / diagnosis
  • Humans
  • Meibomian Glands
  • RNA Splicing Factors
  • RNA*
  • RNA, Messenger
  • Tears

Substances

  • RNA
  • RNA, Messenger
  • SCNM1 protein, human
  • RNA Splicing Factors

Grants and funding

The study was jointly funded by The Regenerative Medicine Unit and The Blood Cell Research Group of the Department of Medical Biochemistry, Oslo University Hospital, and The Faculty of Dentistry, University of Oslo. (Grant number: 751700).